Clinical trials
Recruiting Small Cell Lung Carcinoma trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 3 |
| BioNTech SE | 1 |
| Bristol-Myers Squibb | 1 |
| Daiichi Sankyo | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Maastricht University Medical Center | 1 |
| Seagen, a wholly owned subsidiary of Pfizer | 1 |
| Shanghai Junshi Bioscience Co., Ltd. | 1 |
| Zai Lab (Shanghai) Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Small Cell Lung Carcinoma | 11 |
| Brain Neoplasms | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Colorectal Neoplasms | 1 |
| Lung Neoplasms | 1 |
| Stomach Neoplasms | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.